Accuryn Medical
Patient monitoring platform that detects sepsis and fluid overload in ICU patients via urinary catheter.
Launch date
Employees
Market cap
-
Enterprise valuation
€64—97m (Dealroom.co estimates Apr 2023.)
San Francisco California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $3.9m | Seed | |
$5.0m | Series A | ||
* | $26.6m | Series C | |
N/A | $11.7m | Series D | |
* | N/A | $17.7m | Late VC |
Total Funding | €59.0m |
Related Content
Recent News about Accuryn Medical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.